Media Kit and Investor Information on ALKS Pharmaceutical Stocks

Home Contact Us

ALKS 14.42 ( 0 ) 03.31.20 4:00 PM

About Us

About Alkermes

Our Company Message From the CEO Locations

Leadership

Management Team Board of Directors

Collaborations

Strategic Partners

Products

Products Overview

United States

ARISTADA^® VIVITROL^® Proprietary Products and Technologies Wholesaler and Purchasing Information

European Union

EU Products Using Alkermes Technologies

Research & Development

R&D Overview Our R&D Approach Pipeline Technology Platforms Manufacturing

Other Information

Clinical Trials Expanded Access Investigator Sponsored Studies

Responsibility

Corporate Responsibility Medical Education Grants ALKERMES INSPIRATION GRANTS^® ALKERMES PATHWAYS RESEARCH AWARDS^® Public Policy Investigator Sponsored Studies Corporate Giving and Funding

Investors

Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports

Financials

Snapshot Trading Statistics

Other Information

Email Alerts

News & Events

Press Releases Media Kit

Careers

Working Together Our Core Values Total Rewards Meet Our Employees Recruiting Agencies Equal Opportunity Employer Jobs Overview

Job Opportunities

Field Sales Roles All Available Roles

Home News & Events Media Kit

News & Events

Press Releases Media Kit

Media Kit

As we strive to improve health outcomes for patients worldwide, clear, consistent communication is critical to our success. Here, media can find links to useful information about Alkermes, its products and pipeline and general industry resources.

We welcome inquiries from members of the media and will respond to inquiries as quickly as possible. Write us at mediainfo@alkermes.com.

News & Events

News & Events

Media Kit

Corporate Information

Our Products

Investor Information

News & Events